Loading
Latest filing published 30 Aug 2021 for Kindred Biosciences, Inc., €1.1M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Denise Bevers (board member) discloses dealings in Kindred Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 23 January 2017 to 27 August 2021, the count stands at 29 filings.
Every open-market trade on record is a sale: 7 sales worth €322k. The rest of the record consists of 9 share grants and 12 option exercises. 2021 to date brings no purchases and 5 sales.
Most recently, on 30 August 2021, the filings show a transaction worth €1.1M in Kindred Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration